Marjolein Gysels

Marjolein Gysels

Auto-generated profile, based on publicly available information

Marjolein Gysels

University of Amsterdam Amsterdam Institute of Social Science Research Amsterdam Netherlands

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2013 in BMC Palliative Care
Verified
Journal Article
Open access
PDF file
BGBarbara Gomes
Barbara Gomes
NCNatalia Calanzani
Natalia Calanzani
MGMarjolein Gysels
Marjolein Gysels
SHSue Hall
Sue Hall
IHIrene J Higginson
Irene J Higginson
Home-based models of hospice and palliative care are promoted with the argument that most people prefer to die at home. We examined the heterogeneity in preferences for home death and explored, for the first time, changes of preference with illness progression.

1 December 2014 in The Lancet Respiratory Medicine
Verified
Journal Article
Open access
IHIrene J Higginson
Irene J Higginson
Claudia BauseweinClaudia Bausewein
Claudia Bausewein
CRCharles C Reilly
Charles C Reilly
WGWei Gao
Wei Gao
MGMarjolein Gysels
Marjolein Gysels
JMJohn Moxham
John Moxham
Breathlessness is a common and distressing symptom, which increases in many diseases as they progress and is difficult to manage. We assessed the effectiveness of early palliative care integrated with respiratory services for patients with advanced disease and refractory breathlessness. In this single-blind randomised trial, we enrolled consecutive adults with refractory breathlessness and advanced disease from three large teaching hospitals and via general practitioners in South London. We randomly allocated (1:1) patients to receive either a breathlessness support service or usual care. Randomisation was computer generated centrally by the independent Clinical Trials Unit in a 1:1 ratio, by minimisation to balance four potential confounders: cancer versus non-cancer, breathlessness severity, presence of an informal caregiver, and ethnicity. The breathlessness support service was a short-term, single point of access service integrating palliative care, respiratory medicine, physiotherapy, and occupational therapy. Research interviewers were masked as to which patients were in the treatment group. Our primary outcome was patient-reported breathlessness mastery, a quality of life domain in the Chronic Respiratory Disease Questionnaire, at 6 weeks. All analyses were by intention to treat. Survival was a safety endpoint. This trial is registered with ClinicalTrials.gov, number NCT01165034. Between Oct 22, 2010 and Sept 28, 2012, 105 consenting patients were randomly assigned (53 to breathlessness support service and 52 to usual care). 83 of 105 (78%) patients completed the assessment at week 6. Mastery in the breathlessness support service group improved compared with the control (mean difference 0·58, 95% CI 0·01-1·15, p=0·048; effect size 0·44). Sensitivity analysis found similar results. Survival rate from randomisation to 6 months was better in the breathlessness support service group than in the control group (50 of 53 [94%] vs 39 of 52 [75%]) and in overall survival (generalised Wilcoxon 3·90, p=0·048). Survival differences were significant for patients with chronic obstructive pulmonary disease and interstitial lung disease but not cancer. The breathlessness support service improved breathlessness mastery. Our findings provide robust evidence to support the early integration of palliative care for patients with diseases other than cancer and breathlessness as well as those with cancer. The improvement in survival requires further investigation. UK National Institute for Health Research (NIHR) and Cicely Saunders International.

24 April 2013 in BMC Medicine
Verified
Journal Article
Open access
PDF file
IHIrene J Higginson
Irene J Higginson
CECatherine J Evans
Catherine J Evans
GGGunn Grande
Gunn Grande
NPNancy Preston
Nancy Preston
MMMyfanwy Morgan
Myfanwy Morgan
CTChris Todd
Chris Todd
Despite being a core business of medicine, end of life care (EoLC) is neglected. It is hampered by research that is difficult to conduct with no common standards. We aimed to develop evidence-based guidance on the best methods for the design and conduct of research on EoLC to further knowledge in the field.

1 March 2007 in Respiratory Medicine
Verified
Journal Article
Closed access
Claudia BauseweinClaudia Bausewein
Claudia Bausewein
MFM. Farquhar
M. Farquhar
SBS. Booth
S. Booth
MGM. Gysels
M. Gysels
IHI.J. Higginson
I.J. Higginson

1 October 2008 in BMJ
Verified
Journal Article
Open access
PDF file
CSCathy Shipman
Cathy Shipman
MGMarjolein Gysels
Marjolein Gysels
PWPatrick White
Patrick White
AWAllison Worth
Allison Worth
SMScott A Murray
Scott A Murray
IHIrene J Higginson
Irene J Higginson
Objective To identify major concerns of national and local importance in the provision, commissioning, research, and use of generalist end of life care. Design A national consultation and prioritising exercise using a modified form of the nominal group technique. Participants Healthcare practitioners, commissioners, academics, and representatives of user and voluntary groups. Setting Primary and secondary care, specialist palliative care, and academic and voluntary sectors in England and Scotland. Results 74% of those invited (210/285) participated. The stage of life to which “end of life care” referred was not understood in a uniform way. Perceptions ranged from a period of more than a year to the last few days of life. Prominent concerns included difficulties in prognosis and the availability of adequate support for patients with advanced non-malignant disease. Generalists in both primary and secondary care were usually caring for only a few patients approaching the end of life at any one time at a point in time. It was therefore challenging to maintain skills and expertise particularly as educational opportunities were often limited. End of life care took place among many other competing and incentivised activities for general practitioners in the community. More needs to be known about models of end of life care and how these can be integrated in a generalist’s workload. A greater evidence base is needed about the effectiveness and application of current tools such as the gold standards framework and Liverpool care pathway and about models of palliation in patients with diseases other than cancer. Conclusions Definitions of end of life care need clarification and standardisation. A greater evidence base is needed to define models of good practice together with a commitment to provide education and training and adequate resources for service provision. More needs to be known about the context of provision and the influence of competing priorities and incentives.

1 November 2008 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
MGMarjolein Gysels
Marjolein Gysels
IHIrene J. Higginson
Irene J. Higginson